REGULATORY AFFAIR

Regulatory Affair



Regulatory Affair

Introduction

This paper discussed the similarities and differences of the two studies being done on the costs of drug development and bringing it to the market. Pharmaceutical Research and Development involves complexities. The author DiMasi has favored the high cost of new development in a manner that he has presented the data which derives pharmaceuticals to increase the costs. The reasons he gave in his study were inflation and taxation. Since, pharmaceutical companies recover Research and Development costs through comprehensive patent protection and allowances of taxation. However, the study of Light and Warburton has presented the methods ...